Cimeio Therapeutics announced that it has entered a research collaboration with Kyowa Kirin Co., Ltd. to develop a novel therapy for diseases with high...
National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, announced that William S. Marth, RPh., MBA will become its new...
AcuraStem, a patient-based biotechnology company pioneering the development of treatments for amyotrophic lateral sclerosis (ALS) and additional neurodegenerative diseases, announced the appointment of Marcel...
OmniScience and INmune Bio announced a pioneering partnership to revolutionize operations for INmune Bio’s global Phase 2 Alzheimer’s disease (AD) clinical trial (the “AD02 trial”) using...
